Targeted therapies for pancreatic cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 148-151, 2011.
Article
in Chinese
| WPRIM
| ID: wpr-384310
ABSTRACT
The combination of chemotherapy, radiotherapy and targeted therapies are considered to be major treatments for metastatic pancreatic cancer. At present, the target therapy-related medications include mainly antagonist of epidermal growth factor receptor, monoclonal antibody of vascular endothelial growth factor and so on. Erlotinib combined with gemcitabine has been demonstrated to prolong the survival of patients with pancreatic cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS